Regulation of the immune response to contact sensitizers by Nrf2

Contact Dermatitis. 2022 Jul;87(1):13-19. doi: 10.1111/cod.14073. Epub 2022 Mar 2.

Abstract

The skin is frequently exposed to chemical stress by organic chemicals or metal ions that can directly or indirectly challenge its immune components and may lead to T-cell-mediated delayed-type hypersensitivity reactions. The disruption of the skin's homeostasis by exposure to contact sensitizers (CSs) can trigger an inflammatory immune response that results in eczema and allergic contact dermatitis. The recognition of these chemicals depends on the expression of pattern recognition receptors on sentinel skin cells, mainly the innate resident immune cells orchestrating the skin's immune response and involving both oxidative and inflammatory pathways. The main driver of these both pathways is the Nrf2/Keap1 pathway, a major ubiquitous regulator of cellular oxidative and electrophilic stress, activated in various innate immune cells of the skin, including keratinocytes and epidermal Langerhans cells in the epidermis and dermal dendritic cells in the dermis. Nrf2 also shows a strong protective capacity by downregulating inflammatory pathways. In this review, the important role of Nrf2 in the regulation of the immune response to CSs will be discussed and highlighted.

Keywords: Nrf2; allergic contact dermatitis; contact sensitizers; irritant contact dermatitis.

Publication types

  • Review

MeSH terms

  • Dermatitis, Allergic Contact* / immunology
  • Humans
  • Immunity, Innate
  • Kelch-Like ECH-Associated Protein 1 / metabolism
  • NF-E2-Related Factor 2*
  • Skin / immunology
  • Skin / metabolism

Substances

  • KEAP1 protein, human
  • Kelch-Like ECH-Associated Protein 1
  • NF-E2-Related Factor 2
  • NFE2L2 protein, human